Detalhe da pesquisa
1.
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Blood
; 143(6): 496-506, 2024 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37879047
2.
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Blood
; 137(5): 600-609, 2021 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33538797
3.
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(1): 91-103, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34895487
4.
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
Haematologica
; 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34407608
5.
Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
Haematologica
; 106(9): 2417-2426, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34196165
6.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw
; 19(11): 1218-1230, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34781267
7.
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.
Br J Haematol
; 189(4): 650-660, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32180219
8.
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.
Blood
; 129(16): 2224-2232, 2017 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-28167659
9.
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
N Engl J Med
; 370(11): 1008-18, 2014 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-24450858
10.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
N Engl J Med
; 371(3): 213-23, 2014 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-24881631
11.
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study.
Haematologica
; 106(10): 2774-2778, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34233448
12.
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death.
Blood
; 120(23): 4635-44, 2012 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-23065155
13.
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.
Invest New Drugs
; 32(6): 1246-57, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25142258
14.
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).
Blood Cancer Discov
; 5(1): 21-33, 2024 01 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37983485
15.
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Nat Med
; 2024 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38830991
16.
Primary Autologous Stem Cell Transplantation for Unilateral Primary Central Nervous System Lymphoma-Ophthalmic Variant (Primary Vitreoretinal Lymphoma).
J Vitreoretin Dis
; 7(6): 548-551, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38022793
17.
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study.
EClinicalMedicine
; 56: 101779, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36618900
18.
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.
Clin Cancer Res
; 29(17): 3301-3312, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37364001
19.
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Cancer Discov
; 13(3): 580-597, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36416874
20.
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood
; 115(13): 2578-85, 2010 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19965662